Literature DB >> 22410711

Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.

Ugochukwu C Nzeako1, Hilary J Longhurst.   

Abstract

Angioedema of the intestinal tract is an infrequent but well-described cause of abdominal pain that can occur because of inherited, acquired, allergic, or drug-induced causes. Hereditary angioedema (HAE) is a genetic disorder that causes recurrent attacks of severe edema of various body parts, including the intestinal tract. Moderate to severe abdominal pain occurs in 43-93% of such attacks due to intestinal edema. Laryngeal edema is a potentially life-threatening manifestation. Failure to recognize and diagnose HAE or other causes of intestinal angioedema can lead to years of delay in diagnosis, and in the case of HAE, often to unnecessary abdominal surgeries. Recognizing the typical history of recurrent attacks of abdominal pain, oropharyngeal/laryngeal angioedema or cutaneous angioedema, family history of similar symptoms, association of attacks with stress or menses, and exacerbation of attacks after administration of estrogens or angiotensin-converting enzyme inhibitors will increase diagnostic accuracy. Interdisciplinary treatment is often necessary after the diagnosis of HAE, first with acute management in the emergency room or the intensive care unit, followed by either drug prophylaxis against future attacks using a C1-esterase inhibitor concentrate or attenuated androgens and discontinuation of medications known to trigger attacks. Newer drugs approved for treatment of acute attacks may have future roles in the prevention of attacks if further studies support their efficacy. Gastroenterologists in particular should maintain a high index of suspicion for the possibility of HAE or other causes of intestinal angioedema in patients with a history of recurrent abdominal pain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22410711     DOI: 10.1097/MEG.0b013e3283517998

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

Review 1.  Hereditary angioedema: imaging manifestations and clinical management.

Authors:  Mandip S Gakhal; Gregory V Marcotte
Journal:  Emerg Radiol       Date:  2014-06-01

Review 2.  Hereditary angioedema: what the gastroenterologist needs to know.

Authors:  M Aamir Ali; Marie L Borum
Journal:  Clin Exp Gastroenterol       Date:  2014-11-20

3.  Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.

Authors:  Eitan Rubinstein; Leslie E Stolz; Albert L Sheffer; Chris Stevens; Athos Bousvaros
Journal:  BMC Gastroenterol       Date:  2014-04-09       Impact factor: 3.067

Review 4.  Diagnosis and screening of patients with hereditary angioedema in primary care.

Authors:  Maria Paula Henao; Jennifer L Kraschnewski; Theodore Kelbel; Timothy J Craig
Journal:  Ther Clin Risk Manag       Date:  2016-05-02       Impact factor: 2.423

5.  The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures.

Authors:  Anna Valerieva; Marco Cicardi; James Baraniuk; Maria Staevska
Journal:  Allergy Asthma Clin Immunol       Date:  2018-10-25       Impact factor: 3.406

6.  Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain.

Authors:  Mohamed Abuzakouk; Nada AlMahmeed; Esat Memisoglu; Martine McManus; Aydamir Alrakawi
Journal:  Case Reports Immunol       Date:  2018-10-29

7.  Hereditary Angioedema and Gastrointestinal Complications: An Extensive Review of the Literature.

Authors:  Napoleon Patel; Lisbet D Suarez; Sakshi Kapur; Leonard Bielory
Journal:  Case Reports Immunol       Date:  2015-08-03

Review 8.  Angioedema: Classification, management and emerging therapies for the perioperative physician.

Authors:  Lopa Misra; Narjeet Khurmi; Terrence L Trentman
Journal:  Indian J Anaesth       Date:  2016-08

9.  Idiopathic Thrombocytopenic Purpura Misdiagnosed as Hereditary Angioedema.

Authors:  Michelle Fog Andersen; Anette Bygum
Journal:  Case Rep Dermatol Med       Date:  2015-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.